Lecanemab may slow decline of cognition and function in Alzheimer’s Disease Presented ByProf. Christopher van Dyck, Yale School of Medicine, CT, USA TrialPhase 3, CLARITY AD ConferenceAAN 2023 26 June, 2023 19:44